RE:Unbiased1). You clearly have zero experience in financial modelling
2). You clearly don't understand condcirdia. Their cash flow is great and don't need to do any more acquisitions and have a great and diversified portfolio of assets. They will grow earnings easily bu pying down debt and organically by getting their drugs in the pipeline to market and bring euro drugs over to the US. Should trade near $100 cad within 2 years easily but you for some reason believe these problems ( which to let you know, are fuucking factored into models running different scenarios and rates of discount for the risks ) should value the stock at a future P/E of 2 or something?!?! Where the fuuck are you putting your money if that return isn't good enough for you, even adjusted for the most craziest volatility? My undergrad was in fin modelling and fin economics. Obviously when you reduce your forward estimates in a model by over 30% the stock is going to tank. But it doesn't make sense if the stock is all ready trading at a steep fuucking discount. I don't follow Endo. So don't know what problems they have, but anything here and below for cxr they will easily be bought.